Literature DB >> 2003803

Inhibition of intraocular fibrin formation following infusion of low-molecular-weight heparin during vitrectomy.

D A Iverson1, H Katsura, M K Hartzer, M S Blumenkranz.   

Abstract

We studied the inhibition of intraocular fibrin formation following infusion of 5 IU/mL of low-molecular-weight heparin sodium (Fragmin, KabiVitrum AB, Stockholm, Sweden) during lensectomy, vitrectomy, and retinotomy in the rabbit model. Surgery was performed on 18 eyes, with nine receiving low-molecular-weight heparin and nine serving as controls. Masked postoperative examinations assessed fibrin quantity, corneal clarity, media clarity, and amount of vitreous hemorrhage. Five (56%) of nine eyes receiving low-molecular-weight heparin did not show fibrin exudation development, with the remainder demonstrating a minimal fibrin response. Eight (89%) of nine control eyes demonstrated prominent fibrin exudation, with five (56%) showing development of a fibrin clot that obscured two or more quadrants of the posterior chamber. No significant difference in the degree of vitreous hemorrhage was noted between groups. Corneal clarity was improved in the heparin-treated group.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2003803     DOI: 10.1001/archopht.1991.01080030107048

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  10 in total

1.  Infectious Endophthalmitis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-06       Impact factor: 3.725

2.  Effect of low molecular weight heparin (enoxaparin) on congenital cataract surgery.

Authors:  Ihsan Caça; Alparslan Sahin; Abdullah Kürsat Cingü; Seyhmus Ari; Fuat Alakuş; Yasin Cinar
Journal:  Int J Ophthalmol       Date:  2012-10-18       Impact factor: 1.779

3.  Transplantation of congenitally opaque corneas.

Authors:  B E Frueh; S I Brown
Journal:  Br J Ophthalmol       Date:  1997-12       Impact factor: 4.638

4.  Heparinised intraocular infusion and bacterial contamination in cataract surgery.

Authors:  T D Manners; D P Turner; P H Galloway; A M Glenn
Journal:  Br J Ophthalmol       Date:  1997-11       Impact factor: 4.638

5.  Intracameral tissue plasminogen activator to prevent severe fibrinous effusion after congenital cataract surgery.

Authors:  H Siatiri; A H Beheshtnezhad; H Asghari; N Siatiri; S Moghimi; N Piri
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

6.  A prospective, open-label, dose-escalating study of low molecular weight heparin during repeat vitrectomy for PVR and severe diabetic retinopathy.

Authors:  R Gary Lane; J Michael Jumper; Ma'an A Nasir; Mathew W MacCumber; Brooks W McCuen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-03       Impact factor: 3.117

7.  Effect of heparin in the intraocular irrigating solution on postoperative inflammation in the pediatric cataract surgery.

Authors:  Yelda B Ozkurt; Arzu Taşkiran; Nadire Erdogan; Baran Kandemir; Omer K Doğan
Journal:  Clin Ophthalmol       Date:  2009-06-29

8.  Inhibition of intraocular fibrin formation with annexin V.

Authors:  P Chollet; F Malecaze; F Hullin; P Raynal; J L Arne; V Pagot; J Ragab-Thomas; H Chap
Journal:  Br J Ophthalmol       Date:  1992-08       Impact factor: 4.638

Review 9.  [Proliferative vitreoretinopathy prophylaxis : Mission (im)possible].

Authors:  F Schaub; A M Abdullatif; S Fauser
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

10.  A Step by Step Protocol for Subretinal Surgery in Rabbits.

Authors:  Sami Al-Nawaiseh; Fabian Thieltges; Zengping Liu; Claudine Strack; Ralf Brinken; Norbert Braun; Marc Wolschendorf; Arvydas Maminishkis; Nicole Eter; Boris V Stanzel
Journal:  J Vis Exp       Date:  2016-09-13       Impact factor: 1.355

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.